Summit Securities Group’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,371
Closed -$112K 1175
2025
Q4
$112K Buy
1,371
+1,221
+814% +$95.1K 0.01% 450
2025
Q3
$11.3K Buy
+150
New +$11.2K ﹤0.01% 866
2025
Q1
Sell
-72
Closed -$5.63K 907
2024
Q4
$5.63K Buy
+72
New +$6.12K ﹤0.01% 511
2024
Q3
Sell
-60
Closed -$5K 687
2024
Q2
$5K Buy
+60
New +$4.89K ﹤0.01% 495
2024
Q1
Sell
-37
Closed -$3K 638
2023
Q4
$3K Sell
37
-14
-27% -$980 ﹤0.01% 601
2023
Q3
$3K Sell
51
-19
-27% -$1.38K ﹤0.01% 500
2023
Q2
$6K Sell
70
-641
-90% -$51.2K ﹤0.01% 812
2023
Q1
$58K Buy
+711
New +$50.8K ﹤0.01% 392

Other funds holding GEHC

Summit Securities Group's GEHC Position: Q1 2026 in Review

Summit Securities Group sold out of GE HealthCare (GEHC) in Q1 2026, closing a stake of 1,371 shares — an estimated $112K sold.

Summit Securities Group first reported a position in GEHC in Q1 2023 and held it in 8 quarters. The position peaked at $112K in Q4 2025. 1,263 funds tracked by Wall St. Rank hold GEHC as of Q1 2026.

  • Summit Securities Group reported no remaining GE HealthCare position as of Q1 2026 after selling out during the quarter.
  • Summit Securities Group sold 1,371 GE HealthCare shares in Q1 2026, an estimated $112K.
  • Summit Securities Group first reported a position in GE HealthCare in Q1 2023 and held it in 8 quarters.
  • Summit Securities Group's GE HealthCare position peaked at $112K in Q4 2025.
  • 1,263 funds tracked by Wall St. Rank held GE HealthCare as of Q1 2026.

Based on Summit Securities Group's 13F filing for Q1 2026, filed 30 Apr 2026.